Atlas Trials

Xynomic Pharmaceuticals, Inc.

6 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Xynomic Pharmaceuticals, Inc.

RecordFirmDate
XP-102 and XP-102 in Combination With Trametinib in Advanced Solid Tumor Patients With a BRAF V600 Mutation (NCT05275374)Xynomic Pharmaceuticals, Inc.2025-12-31
A Multi-Center Phase 2 Study to Evaluate Efficacy and Safety of Oral Abexinostat as Monotherapy in Patients With Relapsed or Refractory Follicular Lymphoma (NCT03934567)Xynomic Pharmaceuticals, Inc.2020-04-22
Study to Evaluate Efficacy and Safety of Oral Abexinostat in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (DLBCL) (NCT03936153)Xynomic Pharmaceuticals, Inc.2020-01-20
A Clinical Study to Evaluate Pharmacokinetics, Safety, and Tolerability of Abexinostat in Chinese Patients (NCT04024696)Xynomic Pharmaceuticals, Inc.2020-01-08
Study of Abexinostat in Patients With Relapsed or Refractory Follicular Lymphoma (NCT03600441)Xynomic Pharmaceuticals, Inc.2018-08-27
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV) (NCT03592472)Xynomic Pharmaceuticals, Inc.2018-07-17

Track Xynomic Pharmaceuticals, Inc. automatically

Every clearance here is in the API, with alerts when new ones post.